Waters' Q1 Revenues Slide 2 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today reported a 2 percent decline year over year in revenues for the first quarter, missing Wall Street estimates on the top and bottom line.

For the three months ended March 31, the company posted $420.5 million in total revenues, down from $427.6 million a year ago, and short of consensus analyst estimates of $441.8 million. Foreign currency translation reduced sales growth by 2 percent, Waters said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.